Clinical Trials

Showing 361 - 380 of 454 trials
Titlesort icon Investigator Disease(s)
A Phase I Study of Veliparib Given with Radiation Therapy to the Chest Wall and Lymph Nodes in Patients with Inflammatory or Recurrent Breast Cancer
[Protocol 12-215] 		Ho, Alice
A Phase I Study of TRC105 plus Bevacizumab in Patients with Recurrent Glioma
[Protocol 12-217] 		Omuro, Antonio
  • Brain Tumors, Primary
    • Gliomas
A Phase I Study of Topical Calcitriol (Compound 31543) to Prevent Hair Loss in Women Receiving Paclitaxel for Advanced Breast Cancer
[Protocol 11-205] 		Lacouture, Mario
  • Breast Cancer
A Phase I Study of Tigecycline in Patients with Relapsed or Refractory Acute Myeloid Leukemia
[Protocol 12-148] 		Tallman, Martin
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase I Study of the Treatment of Beta-Thalassemia with a Gene Transfer Approach
[Protocol 10-164] 		Boulad, Farid
  • Hematology
    • Hematologic Disorders
A Phase I Study of the NY-ESO-1 Vaccine plus Ipilimumab in Patients with Inoperable or Metastatic Melanoma
[Protocol 12-253] 		Wolchok, Jedd
  • Melanoma
A Phase I Study of the Hu3F8 Antibody plus GM-CSF in Patients with Relapsed/Refractory Neuroblastoma
[Protocol 12-230] 		Kushner, Brian
  • Neuroblastoma
A Phase I Study of SNX-5422 plus Erlotinib in Patients with Lung Cancer that Has Grown on Erlotinib Therapy
[Protocol 13-035] 		Riely, Gregory
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors
[Protocol 08-091] 		Dunkel, Ira
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase I Study of SGN-CD19A in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
[Protocol 12-282] 		Moskowitz, Craig
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of PU-H71 in Patients with Advanced Cancer
[Protocol 11-041] 		Gerecitano, John
  • Lymphoma
A Phase I Study of PLX3397 in Patients with Advanced Solid Tumors
[Protocol 12-156] 		Tap, William
  • Sarcomas
    • Soft Tissue Sarcoma
  • Thyroid Cancer
A Phase I Study of Plerixafor as a Chemosensitizing Agent for Children with Relapsed Acute Leukemia or Myelodysplastic Syndromes
[Protocol 11-208] 		Trippett, Tanya
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
A Phase I Study of PF-05082566 Alone in Patients with Advanced Cancer, and in Combination with Rituximab in Patients with Non-Hodgkin Lymphoma
[Protocol 11-085] 		Segal, Neil
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of Pegylated Liposomal Doxorubicin, Carboplatin, and Veliparib in Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
[Protocol 12-197] 		Bell-McGuinn, Katherine
  • Ovarian Cancer
A Phase I Study of Panitumumab in Children with Solid Tumors
[Protocol 08-020] 		Meyers, Paul
A Phase I Study of Oral LEE011 in Patients with Advanced Solid Tumors or Lymphomas
[Protocol 10-211] 		Gerecitano, John
  • Lymphoma
A Phase I Study of Oral DS-7423 in Patients with Advanced Solid Tumors
[Protocol 11-144] 		Ho, Alan
A Phase I Study of NEOD001 in Patients with Light Chain Amyloidosis
[Protocol 12-280] 		Landau, Heather
  • Hematology
    • Hematologic Disorders
    • Hematologic Malignancies
A Phase I Study of Narnatumab (IMC-RON8) in Patients with Refractory Solid Tumors
[Protocol 13-018] 		Gounder, Mrinal
  • Solid Tumors